# Off-the-shelf CD123 CAR-NK for R/R AML

> **NCT06201247** · EARLY_PHASE1 · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory

## Interventions

- **DRUG:** JD123 injection

## Key facts

- **NCT ID:** NCT06201247
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-30
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06201247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06201247, "Off-the-shelf CD123 CAR-NK for R/R AML". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06201247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*